,

5-AMINO-1MQ 50mg Capsules

£99.99

& Free Shipping

5-AMINO-1MQ 50mg Capsules contain 5-amino-1-methylquinolinium, an experimental small-molecule NNMT inhibitor studied primarily in metabolic and adipose tissue research. Despite often appearing alongside research peptides, 5-Amino-1MQ is not a peptide. Its main research target is the enzyme nicotinamide N-methyltransferase (NNMT).

Interest in 5-Amino-1MQ centres on the role NNMT plays in nicotinamide metabolism, NAD+ availability and the metabolic behaviour of fat cells. Preclinical studies have investigated inhibiting NNMT in white adipose tissue, including models of diet-induced obesity.

What Is 5-Amino-1MQ?

5-Amino-1MQ is a synthetic small molecule developed to inhibit nicotinamide N-methyltransferase (NNMT). NNMT is an enzyme that transfers a methyl group from S-adenosylmethionine (SAM) to nicotinamide, producing 1-methylnicotinamide (1-MNA).

This reaction is important to researchers because nicotinamide can also be recycled through the NAD+ salvage pathway. NAD+ is a coenzyme involved in cellular energy metabolism, redox reactions and the activity of NAD+-dependent enzymes.

Rather than supplying NAD+ or acting as an NAD supplement, 5-Amino-1MQ provides researchers with a way of studying what happens when one pathway that consumes nicotinamide is inhibited.

Why Is 5-Amino-1MQ Researched?

A major area of interest is adipose tissue. NNMT expression and activity have been linked with metabolic changes in white adipose tissue, making the enzyme a potential target for investigating how fat cells store and process energy.

5-Amino-1MQ has therefore been used in laboratory and animal models to examine NNMT inhibition without directly targeting appetite-related receptors.

This distinction is particularly relevant when discussing appetite suppression. In a widely cited study involving diet-induced obese mice, researchers observed reductions in body weight and white adipose tissue without a significant change in food intake. This suggests the findings could not simply be explained by the animals consuming less food.

What Have Studies Found?

Preclinical research has produced some of the most interesting findings around fat mass and adipocyte structure.

In diet-induced obesity models, researchers have investigated outcomes including:

  • Reduced white adipose tissue mass
  • Smaller fat cells
  • Changes in overall fat cell size
  • Reduced lipogenesis in cultured adipocytes
  • Changes in body weight without significantly reduced food intake
  • Alterations in NAD+ concentrations following NNMT inhibition

The observation of smaller fat cells is particularly relevant to the mechanism being studied. Instead of simply measuring total body weight, researchers were able to examine changes directly within adipose tissue.

These results come from preclinical models. There are currently no published controlled human trials establishing 5-Amino-1MQ as a treatment for reducing fat mass or producing long-term weight loss in people.

5-Amino-1MQ And NAD Levels

The relationship between NNMT and NAD+ provides another distinct area of research.

NNMT uses nicotinamide to produce 1-MNA. Nicotinamide can alternatively act as a precursor within the NAD+ salvage pathway, so researchers have investigated whether inhibiting NNMT changes intracellular NAD levels.

Experiments involving cultured adipocytes have reported increased intracellular NAD+ concentrations following NNMT inhibition with 5-Amino-1MQ. The original research reported concentration-dependent increases of approximately 1.2 to 1.6-fold under the experimental conditions studied. :contentReference[oaicite:1]{index=1}

NAD+ participates in numerous cellular processes, including mitochondrial function and cellular energy metabolism. It is also required by enzymes including sirtuins.

However, 5-Amino-1MQ should not be described as directly causing sirtuin activation. The research interest instead comes from whether changing NAD+ availability through NNMT inhibition could influence NAD+-dependent cellular pathways.

Fat Oxidation And Energy Expenditure Research

Another area being investigated is the relationship between NNMT and the way adipose tissue handles stored energy.

Research into NNMT has examined metabolic processes involving lipogenesis, fat oxidation and energy expenditure. These processes determine whether nutrients are stored within adipocytes or used to meet cellular energy requirements.

This provides a possible metabolic explanation for why changes in adipose mass and fat cell size have been observed without corresponding appetite suppression in animal experiments.

Researchers are also interested in the wider relationship between NAD+ metabolism, mitochondrial function and cellular energy. These pathways are closely connected, but findings from experimental models should not be treated as evidence of increased human metabolism or proven fat-burning effects.

Why White Adipose Tissue Matters

White adipose tissue does considerably more than store excess energy. It is metabolically active tissue involved in nutrient storage, hormone signalling and wider metabolic regulation.

Changes in the size and behaviour of adipocytes can therefore provide researchers with more information than changes in total body weight alone.

By inhibiting NNMT, 5-Amino-1MQ allows researchers to examine how this enzyme contributes to adipocyte metabolism and whether changing its activity alters the balance between energy storage and utilisation.

This focus on cellular metabolism separates 5-Amino-1MQ research from compounds primarily investigated through appetite, GLP-1 or central nervous system pathways.

Quality Control & Capsule Format

5-AMINO-1MQ 50mg Capsules provide the compound in a capsule-based research format. Because 5-Amino-1MQ is a chemically defined small molecule rather than a peptide, its analytical profile and quality control requirements are different from conventional peptide products.

Compound identity, purity and chemical form should be assessed against the applicable batch documentation and Certificate of Analysis where provided.

This is particularly important with 5-Amino-1MQ because different salt forms may be referenced by suppliers, resulting in differences in molecular formula and molecular weight. The specification for the individual batch should therefore take priority over generic values found online.

Storage

5-AMINO-1MQ 50mg Capsules should be stored according to the conditions specified within the applicable product and batch documentation. Keep the formulation protected from excessive heat, direct light and moisture and maintain consistent conditions during laboratory storage.

Long-term human safety and effectiveness have not been established.

 

SKU: 5AMINO1MQ-CAPSULES-50MG Categories: ,

5-AMINO-1MQ 50mg Capsules – Advanced NNMT Research Compound

5-AMINO-1MQ 50mg Capsules contain 5-amino-1-methylquinolinium, an experimental small-molecule compound investigated primarily for its relationship with nicotinamide N-methyltransferase (NNMT), nicotinamide metabolism, NAD+ biology, adipose tissue function, and cellular metabolic pathways.

Although 5-Amino-1MQ is frequently discussed alongside research peptides and other experimental compounds, it is important to clarify that 5-Amino-1MQ is not a peptide. It is a chemically defined small molecule that researchers study primarily as an NNMT inhibitor.

Interest in 5-AMINO-1MQ 50mg Capsules has grown because NNMT is involved in the metabolism of nicotinamide, a molecule connected to the NAD+ salvage pathway. Researchers have therefore investigated whether altering NNMT activity can influence intracellular NAD+ availability and metabolic processes within adipose tissue.

Preclinical research has examined 5-Amino-1MQ in cultured cells and animal models, including experimental models of diet-induced obesity. Areas of investigation have included adipocyte size, white adipose tissue mass, lipogenesis, energy metabolism, and changes in intracellular NAD+ concentrations.

The capsule presentation provides a convenient solid format for laboratory research and analytical applications where a defined quantity of small-molecule material is required.

For research use only. Not for human or veterinary use.

What Is 5-AMINO-1MQ?

5-Amino-1MQ is a synthetic small molecule investigated for its ability to inhibit the enzyme nicotinamide N-methyltransferase, commonly abbreviated as NNMT.

NNMT is an enzyme involved in nicotinamide metabolism. It catalyses the transfer of a methyl group from S-adenosylmethionine, or SAM, to nicotinamide, producing 1-methylnicotinamide (1-MNA).

This biochemical reaction is particularly interesting to researchers because nicotinamide is also connected with the NAD+ salvage pathway.

NAD+, or nicotinamide adenine dinucleotide, is an important cellular coenzyme involved in:

  • Energy metabolism
  • Redox reactions
  • Mitochondrial function
  • Cellular signalling
  • Enzyme activity
  • Metabolic regulation

By studying NNMT inhibition, researchers can investigate how changes in nicotinamide metabolism may influence NAD+ availability and related cellular processes.

Is 5-Amino-1MQ a Peptide?

No. 5-Amino-1MQ is not a peptide.

It is a synthetic small-molecule compound.

This distinction is important because small molecules and peptides can have significantly different chemical characteristics, including differences in:

  • Molecular structure
  • Molecular weight
  • Solubility
  • Stability
  • Analytical testing
  • Formulation
  • Laboratory handling

The 5-AMINO-1MQ 50mg Capsules format therefore differs from conventional lyophilised research peptides.

Understanding this distinction also helps researchers select appropriate analytical techniques and laboratory procedures for evaluating the material.

What Is NNMT?

Nicotinamide N-methyltransferase, or NNMT, is an enzyme involved in the metabolism of nicotinamide.

NNMT uses SAM as a methyl donor and converts nicotinamide into 1-methylnicotinamide.

This pathway has become an area of metabolic research because nicotinamide is also involved in NAD+ recycling.

Researchers are interested in understanding how changes in NNMT activity may influence:

  • Nicotinamide metabolism
  • NAD+ availability
  • Cellular energy metabolism
  • Adipocyte biology
  • Mitochondrial processes
  • Metabolic signalling

5-Amino-1MQ provides an experimental approach for investigating these relationships.

How 5-Amino-1MQ Works in Research

The primary research interest surrounding 5-Amino-1MQ comes from its activity as an NNMT inhibitor.

By inhibiting NNMT, researchers can investigate what happens when the conversion of nicotinamide into 1-MNA is reduced.

This provides an experimental model for studying how nicotinamide may be redistributed within cellular metabolic pathways.

In simplified terms, researchers can examine whether NNMT inhibition influences:

  • Intracellular nicotinamide availability
  • NAD+ metabolism
  • Adipocyte metabolism
  • Lipid storage
  • Energy utilisation
  • Cellular metabolic signalling

The purpose of this research is to understand the biological role of NNMT and its associated pathways rather than establish 5-Amino-1MQ as a clinical treatment.

Why Researchers Study 5-Amino-1MQ

The growing scientific interest in 5-AMINO-1MQ 50mg Capsules is closely associated with research into metabolism and adipose tissue.

NNMT expression has been investigated in adipose tissue, and researchers have explored whether changes in NNMT activity can affect how fat cells store and process energy.

Preclinical experiments have therefore examined 5-Amino-1MQ in models involving:

  • White adipose tissue
  • Adipocyte biology
  • Fat storage
  • Lipogenesis
  • Fat oxidation
  • Energy expenditure
  • NAD+ metabolism
  • Metabolic adaptation

These areas are especially relevant to researchers studying the molecular mechanisms underlying metabolic regulation.

5-Amino-1MQ and White Adipose Tissue

White adipose tissue is a metabolically active tissue that stores energy in the form of triglycerides.

Adipose tissue also participates in endocrine signalling and communicates with other organs through hormones and signalling molecules.

Because NNMT has been investigated in adipose tissue, researchers have used 5-Amino-1MQ to explore whether inhibiting the enzyme changes adipocyte behaviour.

Research models may examine:

  • Adipocyte size
  • White adipose tissue mass
  • Lipid storage
  • Lipogenesis
  • Cellular energy metabolism
  • Metabolic signalling

These studies can provide insight into the molecular pathways controlling how adipose tissue stores and uses energy.

5-Amino-1MQ and Adipocyte Research

Adipocytes are specialised cells responsible for storing and releasing energy.

Their size, number, lipid content, and metabolic activity can change in response to nutritional and hormonal conditions.

Researchers have investigated whether NNMT inhibition influences adipocyte characteristics.

Experimental observations have included investigations into:

  • Fat-cell size
  • Lipid accumulation
  • Lipogenesis
  • Energy expenditure
  • Cellular NAD+ levels
  • Metabolic gene expression

This makes 5-Amino-1MQ an interesting tool for studying the relationship between enzyme activity and adipocyte metabolism.

5-Amino-1MQ and NAD+ Metabolism

One of the most important research areas involving 5-AMINO-1MQ 50mg Capsules is the relationship between NNMT and NAD+ metabolism.

NAD+ is an essential cellular cofactor involved in energy transfer and numerous enzymatic reactions.

Cells maintain NAD+ through several interconnected pathways. The NAD+ salvage pathway is particularly important because it allows cells to recycle nicotinamide into NAD+.

NNMT represents another route through which nicotinamide can be metabolised.

Researchers therefore investigate whether inhibiting NNMT changes the amount of nicotinamide available for NAD+ synthesis.

This creates an interesting experimental connection between:

  • NNMT activity
  • Nicotinamide metabolism
  • NAD+ availability
  • Cellular energy production
  • Mitochondrial function
  • NAD+-dependent enzymes

NAD+ and Cellular Energy Research

NAD+ participates in numerous cellular reactions.

It functions as an electron carrier during metabolic reactions and helps cells transfer energy through processes involving oxidation and reduction.

NAD+ is also required by several classes of enzymes involved in cellular signalling and maintenance.

Researchers studying 5-Amino-1MQ are therefore interested in whether changes in NNMT activity can influence the cellular NAD+ pool.

This research does not mean that 5-Amino-1MQ is an NAD+ supplement. Instead, the compound is used experimentally to investigate one of the pathways involved in nicotinamide metabolism.

That distinction is important when interpreting research findings.

5-Amino-1MQ and Intracellular NAD+

Preclinical research has examined intracellular NAD+ concentrations following NNMT inhibition.

In cultured adipocyte models, experimental NNMT inhibition has been associated with changes in intracellular NAD+ levels under specific laboratory conditions.

These observations are significant because they provide researchers with a way to investigate the relationship between nicotinamide metabolism and cellular NAD+ availability.

However, experimental changes in cellular NAD+ should not automatically be interpreted as evidence of improved metabolism or increased energy in humans.

The biological response depends on the experimental model, concentration, exposure period, cell type, and other laboratory conditions.

5-Amino-1MQ and Lipogenesis Research

Lipogenesis refers to the process through which cells synthesise and store lipids.

Adipocytes are highly specialised for lipid storage, making lipogenesis an important area of adipose tissue research.

Researchers have investigated whether NNMT inhibition affects lipogenic activity.

Laboratory models may measure:

  • Lipid accumulation
  • Fatty-acid synthesis
  • Adipocyte differentiation
  • Cellular triglyceride content
  • Expression of metabolic genes

These measurements help scientists understand how metabolic enzymes influence the behaviour of fat cells.

5-Amino-1MQ and Fat Oxidation Research

Fat oxidation refers to the metabolic breakdown of fatty acids for energy.

The balance between lipid storage and lipid utilisation is an important component of cellular metabolism.

Because NNMT is involved in metabolic pathways, researchers have investigated whether inhibiting the enzyme influences processes related to fat utilisation.

Experimental research can examine:

  • Fatty-acid oxidation
  • Mitochondrial activity
  • Energy expenditure
  • Lipid metabolism
  • Cellular fuel utilisation

These findings contribute to broader research into how cells regulate energy availability.

5-Amino-1MQ and Energy Expenditure

Energy expenditure describes the amount of energy used by an organism or biological system.

Researchers studying metabolic compounds may measure changes in energy expenditure to understand how experimental interventions influence whole-body metabolism.

In preclinical research, 5-Amino-1MQ has attracted attention because NNMT inhibition has been associated with metabolic changes in animal models.

However, observations in animals should not be presented as proof of increased energy expenditure in humans.

Further research is necessary to establish how these mechanisms translate across different biological systems.

5-Amino-1MQ and Diet-Induced Obesity Models

One of the better-known areas of preclinical 5-Amino-1MQ research involves diet-induced obesity models.

These models are used by researchers to investigate metabolic changes associated with long-term exposure to energy-dense diets.

Experimental studies have examined whether NNMT inhibition changes metabolic characteristics within these models.

Researchers have investigated outcomes including:

  • Body-weight changes
  • White adipose tissue mass
  • Adipocyte size
  • Food intake
  • Lipid metabolism
  • Energy expenditure
  • Cellular NAD+ concentrations

An important observation from some preclinical research is that changes in body weight and adipose tissue were not necessarily accompanied by a corresponding reduction in food intake.

This has encouraged researchers to investigate metabolic mechanisms beyond appetite regulation.

Does 5-Amino-1MQ Suppress Appetite?

Appetite suppression is not considered the primary mechanism of 5-Amino-1MQ research.

Unlike compounds designed to interact with appetite-related hormone receptors, 5-Amino-1MQ is primarily investigated as an NNMT inhibitor.

Some animal research has observed changes in body weight and adipose tissue without a major reduction in food intake.

This distinction is scientifically important because it suggests that metabolic pathways may be contributing to the observations rather than simple changes in food consumption.

Nevertheless, these findings are based on preclinical models and should not be interpreted as evidence that 5-Amino-1MQ suppresses appetite in humans.

5-Amino-1MQ and Metabolic Research

The relationship between NNMT, nicotinamide, NAD+, and adipose tissue makes 5-Amino-1MQ particularly relevant to metabolic research.

Researchers can use the compound to investigate how a specific enzyme influences broader cellular pathways.

Research areas include:

  • Cellular metabolism
  • Adipose tissue biology
  • NAD+ metabolism
  • Nicotinamide metabolism
  • Lipid storage
  • Fatty-acid oxidation
  • Mitochondrial function
  • Energy expenditure

This broad research relevance has contributed to continued scientific interest in NNMT inhibitors.

5-Amino-1MQ and Mitochondrial Research

Mitochondria are responsible for producing much of the usable energy within cells.

Because NAD+ is involved in cellular energy metabolism, researchers have considered relationships between NNMT inhibition, NAD+ availability, and mitochondrial activity.

Experimental models may investigate:

  • Mitochondrial respiration
  • Cellular energy production
  • Oxidative metabolism
  • NAD+/NADH balance
  • Fatty-acid utilisation
  • Metabolic adaptation

These investigations help researchers understand whether changes in nicotinamide metabolism influence wider cellular energy pathways.

5-Amino-1MQ and Cellular Signalling

NAD+ is involved in more than energy metabolism.

It is also required by several NAD+-dependent enzymes involved in cellular signalling and regulation.

For this reason, changes in NAD+ availability may have downstream implications for multiple cellular processes.

Researchers studying 5-Amino-1MQ can therefore investigate relationships between:

  • NNMT inhibition
  • NAD+ availability
  • Enzyme activity
  • Cellular signalling
  • Metabolic regulation
  • Cellular stress responses

This provides a broader framework for understanding why NNMT has become an area of interest in molecular biology.

Why White Adipose Tissue Is Important

White adipose tissue is much more than a passive energy-storage compartment.

It plays important roles in:

  • Energy storage
  • Hormonal communication
  • Lipid metabolism
  • Nutrient handling
  • Metabolic signalling

Changes in adipocyte size and behaviour can therefore provide valuable information about metabolic health in experimental models.

By investigating NNMT within adipose tissue, researchers can examine how this enzyme contributes to the balance between nutrient storage and utilisation.

The 5-AMINO-1MQ 50mg Capsules research format provides a defined compound for investigating these pathways under controlled conditions.

5-Amino-1MQ Research vs Appetite-Targeted Compounds

The mechanism of 5-Amino-1MQ is different from that of compounds primarily investigated for appetite-related receptor signalling.

5-Amino-1MQ research centres on NNMT inhibition and metabolic pathways involving nicotinamide.

This creates a different research model focused on cellular metabolism rather than directly targeting appetite receptors.

Researchers can therefore use NNMT inhibition to investigate metabolic biology from another perspective.

Areas of comparison may include:

  • Cellular metabolism
  • Energy utilisation
  • Adipocyte biology
  • NAD+ metabolism
  • Lipid storage
  • Appetite-independent metabolic pathways

Quality Control for 5-Amino-1MQ

Quality control is particularly important when working with chemically defined small molecules.

Research outcomes can be affected by impurities, degradation products, incorrect concentration, or differences in chemical form.

For 5-AMINO-1MQ 50mg Capsules, researchers should consider relevant analytical documentation, including information relating to:

  • Compound identity
  • Chemical purity
  • Quantity
  • Batch information
  • Chemical form
  • Analytical testing
  • Storage conditions

Where a Certificate of Analysis is supplied, researchers should use the batch-specific documentation as the primary reference for product specifications.

Capsule Format

The capsule presentation offers a convenient solid format for research environments.

Unlike many lyophilised peptide products, 5-AMINO-1MQ 50mg Capsules do not require the same type of peptide reconstitution process.

The defined capsule format can simplify material identification and storage within an organised research workflow.

Researchers should nevertheless handle the material according to applicable laboratory procedures and product documentation.

Storage and Handling

5-AMINO-1MQ 50mg Capsules should be stored according to the applicable product and batch documentation.

The material should generally be protected from environmental conditions that could compromise chemical stability, including:

  • Excessive heat
  • Direct sunlight
  • Moisture
  • Unstable temperature conditions
  • Contamination

Keeping the original packaging appropriately sealed can help reduce unnecessary environmental exposure.

For extended research projects, laboratories should establish suitable storage and documentation procedures based on the characteristics of the specific material.

Research Applications

The 5-AMINO-1MQ 50mg Capsules format can be relevant to several areas of laboratory investigation.

NNMT Research

Studies examining the activity and biological significance of nicotinamide N-methyltransferase.

NAD+ Research

Investigation into relationships between nicotinamide metabolism and cellular NAD+ availability.

Adipose Tissue Research

Experimental studies examining white adipose tissue and adipocyte biology.

Metabolic Research

Research into energy utilisation, lipid metabolism, and metabolic regulation.

Mitochondrial Research

Investigation of cellular energy production and oxidative metabolism.

Cellular Signalling Research

Studies examining NAD+-dependent pathways and metabolic signalling.

Obesity Model Research

Preclinical investigation using experimental models of altered adipose tissue and energy balance.

Experimental Considerations

When using small-molecule compounds in research, researchers should carefully control experimental variables.

Important considerations can include:

  • Compound identity
  • Purity
  • Experimental concentration
  • Cell type or biological model
  • Exposure duration
  • Environmental conditions
  • Analytical method
  • Control groups
  • Measurement techniques

Controlling these factors can improve reproducibility and make it easier to compare findings between experiments.

Safety and Research Limitations

5-Amino-1MQ remains an experimental research compound.

Although preclinical studies have produced interesting findings involving NNMT inhibition and metabolic pathways, these results do not establish the compound as safe or effective for human use.

Important limitations include:

  • Limited human research
  • Lack of established long-term safety data
  • Differences between animal and human biology
  • Differences between laboratory models
  • Uncertainty surrounding prolonged exposure
  • Potential formulation differences

Researchers should conduct appropriate risk assessments and consult applicable safety documentation before handling experimental materials.

Is 5-Amino-1MQ an NAD+ Supplement?

No.

5-Amino-1MQ is not an NAD+ supplement and does not simply provide NAD+ to cells.

Its research relevance comes from its ability to inhibit NNMT, an enzyme involved in nicotinamide metabolism.

Researchers investigate whether changing NNMT activity can alter the availability of nicotinamide for other metabolic pathways, including the NAD+ salvage pathway.

Is 5-Amino-1MQ a Peptide?

No. 5-Amino-1MQ is a synthetic small molecule.

Although it may be marketed alongside research peptides, its chemical structure and laboratory characteristics are fundamentally different from peptide compounds.

What Does NNMT Stand For?

NNMT stands for nicotinamide N-methyltransferase.

It is an enzyme that participates in nicotinamide metabolism by transferring a methyl group from SAM to nicotinamide.

The enzyme has become an important subject in metabolic research because of its relationship with nicotinamide and NAD+ pathways.

Why Is 5-Amino-1MQ Studied in Fat Cells?

NNMT has been investigated in adipose tissue, making fat cells an important experimental model.

Researchers study 5-Amino-1MQ to investigate whether inhibiting NNMT changes adipocyte metabolism, lipid storage, cellular NAD+ concentrations, and related metabolic processes.

Has 5-Amino-1MQ Been Studied in Animals?

Yes. Preclinical research has investigated 5-Amino-1MQ in animal models, including models designed to study diet-induced obesity and metabolic changes.

Researchers have examined outcomes such as adipose tissue mass, adipocyte size, body weight, food intake, and metabolic pathways.

These findings remain preclinical and cannot automatically be applied to humans.

Does 5-Amino-1MQ Increase NAD+?

Research has investigated whether NNMT inhibition with 5-Amino-1MQ can influence intracellular NAD+ concentrations.

Some experimental studies have reported increases in intracellular NAD+ under specific laboratory conditions.

However, the response depends on the experimental model and should not be interpreted as proof that the compound increases NAD+ in humans.

Product Specifications

Product Name: 5-AMINO-1MQ 50mg Capsules
Research Compound: 5-Amino-1MQ
Chemical Classification: Synthetic small molecule
Primary Target: Nicotinamide N-methyltransferase (NNMT)
Quantity: 50mg
Format: Capsules
Primary Research Areas: NNMT inhibition, NAD+ metabolism, adipose tissue research, metabolic biology
Additional Research Areas: Lipid metabolism, cellular energy, mitochondrial research, adipocyte biology
Reconstitution: Not required for capsule presentation
Intended Use: Laboratory research and scientific investigation
Human Use: Not intended
Veterinary Use: Not intended

5-AMINO-1MQ 50mg Capsules
5-AMINO-1MQ 50mg Capsules
5-AMINO-1MQ 50mg Capsules
5-AMINO-1MQ 50mg Capsules
5-AMINO-1MQ 50mg Capsules
5-AMINO-1MQ 50mg Capsules
5-AMINO-1MQ 50mg Capsules 5-AMINO-1MQ 50mg Capsules 5-AMINO-1MQ 50mg Capsules 5-AMINO-1MQ 50mg Capsules 5-AMINO-1MQ 50mg Capsules 5-AMINO-1MQ 50mg Capsules 5-AMINO-1MQ 50mg Capsules 5-AMINO-1MQ 50mg Capsules 5-AMINO-1MQ 50mg Capsules 5-AMINO-1MQ 50mg Capsules 5-AMINO-1MQ 50mg Capsules 5-AMINO-1MQ 50mg Capsules 5-AMINO-1MQ 50mg Capsules 5-AMINO-1MQ 50mg Capsules 5-AMINO-1MQ 50mg Capsules 5-AMINO-1MQ 50mg Capsules 5-AMINO-1MQ 50mg Capsules 5-AMINO-1MQ 50mg Capsules

Final Research Summary

5-AMINO-1MQ 50mg Capsules provide a defined small-molecule research formulation for scientific investigations involving NNMT inhibition, nicotinamide metabolism, NAD+ biology, adipose tissue, and cellular metabolic pathways.

5-Amino-1MQ is distinct from conventional research peptides because it is a synthetic small molecule. Its primary research interest comes from its interaction with nicotinamide N-methyltransferase (NNMT), an enzyme that metabolises nicotinamide into 1-methylnicotinamide.

Researchers are particularly interested in NNMT because nicotinamide is also connected with the NAD+ salvage pathway. Experimental inhibition of NNMT therefore provides a way to investigate relationships between nicotinamide metabolism, intracellular NAD+ availability, cellular energy metabolism, and adipose tissue biology.

Preclinical studies have investigated 5-Amino-1MQ in cultured adipocytes and animal models, including diet-induced obesity models. Areas of research have included white adipose tissue mass, adipocyte size, lipogenesis, fat oxidation, energy expenditure, food intake, and intracellular NAD+ concentrations.

The 5-AMINO-1MQ 50mg Capsules presentation provides a convenient solid format for controlled research environments and does not require the same reconstitution procedures used for lyophilised peptide powders.

As with all experimental compounds, research findings should be interpreted according to the specific model, methodology, concentration, exposure period, and analytical conditions used. Preclinical observations should not be presented as established human benefits, safety conclusions, or therapeutic recommendations.

5-AMINO-1MQ 50mg Capsules are supplied strictly for laboratory research, analytical testing, and scientific investigation. Not for human or veterinary use.

Shopping Cart